August 30, 2016 10:59 AM ET

Biotechnology

Company Overview of Boston BioCom LLC

Key Executives for Boston BioCom LLC

NameBoard RelationshipsTitleAge
Frank A. Dinucci 14 RelationshipsChief Executive Officer, President and Member of Board of Managers--
Jan Andrew Buck 13 RelationshipsFounder and Strategic Advisor--
Hamed Abdou No RelationshipsVice President of Operations--

Boston BioCom LLC Board Members*

NameBoard RelationshipsPrimary CompanyAge
Frank A. Dinucci 14 RelationshipsBoston BioCom LLC--
Jeffrey A. Gelfand M.D. 50 RelationshipsBoston BioCom LLC--
Charles A. Sanders M.D. 147 RelationshipsBiodel Inc.84
Barbara J. Dalton Ph.D. 150 RelationshipsPfizer Inc.63
Michael J. Brownstein Prof. M.D., Ph.D. 96 RelationshipsExponential Biotherapies, Inc.--
View All Board Members

Boston BioCom LLC Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board M.D.Jeffrey A. Gelfand50 Relationships10 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
379.6K
Bonus
261.7K
Total Short Term Compensation
475.8K
Total Value of Options
33.3M
Compensation as of Fiscal Year
Boston BioCom LLC CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Bone Therapeutics SA Appoints Benoît Champluvier as Chief Technology and Manufacturing Officer
August 30, 2016 5:00 AM ET
Adverum Biotechnologies, Inc. Announces Resignation of John P. McLaughlin as Member of the Board of Directors, Chairman and Member of the Audit Committee and Member of the Compensation and Nominating and Corporate Governance Committees of the Board, Effective as of August 31, 2016
August 29, 2016 8:44 PM ET
OncoCyte Corporation Announces Board Changes
August 29, 2016 8:15 PM ET
Leap Therapeutics, Inc. and Macrocure Ltd. Announce Management Changes
August 29, 2016 12:51 PM ET
FORMA Therapeutics, Inc. Appoints Karoline Shair as Vice President, Legal and Chief Intellectual Property Counsel
August 29, 2016 12:00 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Boston BioCom LLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.